Association between T174M polymorphism in the angiotensinogen gene and risk of coronary artery disease: A meta-analysis

Journal of Geriatric Cardiology

Volumn 10, Issue 1, 2013, Pages 59-65

  Wang, Wen Zhu ^a  

^a PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Angiotensinogen; Coronary artery disease; Meta analysis; Polymorphism

Indexed keywords

ANGIOTENSINOGEN GENE; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DNA POLYMORPHISM; ETHNICITY; GENE; GENETIC ASSOCIATION; HUMAN; META ANALYSIS;

EID: 84878968505     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1671-5411.2013.01.010     Document Type: Article

References (34)

1. McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors. N Engl J Med 1996; 334: 884-890. (Pubitemid 26107346)
2. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011; 123: 933-944.
3. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart Disease and Stroke Statistics-2012 Update: A Report From the American Heart Association. Circulation 2012; 125: e2-e220.
4. Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003; 290: 891- 897.
5. Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med 2010; 2: 247-257.
6. Sivitskaia LN, Kushnerevich EI, Danilenko NG, et al. Gene polymorphism of the renin-angiotensin system in six ethnic/ geographic regions of Belarus. Genetika 2008; 44: 702-709.
7. Tiret L, Ricard S, Poirier O, et al. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM Study. J Hypertens 1995; 13: 311-317.
8. Chen D, Liu JL, Liu Y, et al. Lack of an association between -308G>A polymorphism of the TNF-α gene and liver cirrhosis risk based on a meta-analysis. Genet Mol Res 2011; 10: 2765-2774.
9. Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 2003; 56: 297-303. (Pubitemid 36593307)
10. Wenzel K, Blackburn A, Ernst M, et al. Relationship of polymorphisms in the renin-angiotensin system and in E-selectin of patients with early severe coronary heart disease. J Mol Med 1997; 75: 57-61. (Pubitemid 27067140)
11. Ichihara S, Yokota M, Fujimura T, et al. Lack of association between variants of the angiotensinogen gene and the risk of coronary artery disease in middle-aged Japanese men. Am Heart J 1997; 134: 260-265. (Pubitemid 27406689)
12. Ko YL, Ko YS, Wang SM, et al. Angiotensinogen and angiotensin-I converting enzyme gene polymorphisms and the risk of coronary artery disease in Chinese. Hum Genet 1997; 100: 210 -214.
13. Sheu WH, Lee WJ, Jeng CY, et al. Angiotensinogen gene polymorphism is associated with insulin resistance in nondiabetic men with or without coronary heart disease. Am Heart J 1998; 136: 125-131. (Pubitemid 28317877)
14. Frossard PM, Hill SH, Elshahat YI, et al. Associations of angiotensinogen gene mutations with hypertension and myocardial infarction in a gulf population. Clin Genet 1998; 54: 285-293. (Pubitemid 28479308)
15. Cong ND, Hamaguchi K, Saikawa T, et al. A polymorphism of angiotensinogen gene codon 174 and coronary artery disease in Japanese subjects. Am J Med Sci 1998; 316: 339-344. (Pubitemid 28525032)
16. Gardemann A, Stricker J, Humme J, et al. Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis. Atherosclerosis 1999; 145: 309 -314.
17. Fatini C, Abbate R, Pepe G, et al. Searching for a better assessment of the individual coronary risk profile: the role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. Eur Heart J 2000; 21: 633- 638.
18. Spiridonova MG, Stepanov VA, Puzyrev VP, et al. Association between polymorphism T174M of the angiotensinogen gene and coronary atherosclerosis in the Tomsk population. Mol Biol 2001; 35: 11-14. (Pubitemid 33384413)
19. Babunova NB, Minushkina LO, Zateishchikov DA, et al. Association of the T174M and M235T polymorphisms of the angiotensinogen gene with coronary heart disease in ethnic Russians from Moscow. Mol Biol 2003; 37: 52-55.
20. Nair KG, Shalia KK, Ashavaid TF, et al. Coronary heart disease, hypertension, and angiotensinogen gene variants in Indian population. J Clin Lab Anal 2003; 17: 141-146. (Pubitemid 37128652)
21. Zhang AP, Ning SC, Li ZQ, et al. Polymorphism of angiotensinogen gene is associated with myocardial infarction in Chinese Han population. J Fourth Mil Med Univ 2005; 26: 729-731.
22. Renner W, Nauck M, Winkelmann BR, et al. Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. J Mol Med (Berl) 2005; 83: 235-239. (Pubitemid 40487412)
23. Tsai CT, Hwang JJ, Ritchie MD, et al. Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction. Atherosclerosis 2007; 195: 172-180. (Pubitemid 47561934)
24. Freitas AI, Mendonça I, Brión M, et al. RAS gene polymorphisms, classical risk factors and the advent of coronary artery disease in the Portuguese population. BMC Cardiovasc Disord 2008; 8: 15.
25. Abboud N, Ghazouani L, Kaabi B, et al. Evaluation of the contribution of renin angiotensin system polymorphisms to the risk of coronary artery disease among Tunisians. Genet Test Mol Biomarkers 2010; 14: 661-666.
26. Konopka A, Szperl M, Piotrowski W, et al. Influence of renin-angiotensin system gene polymorphisms on the risk of ST-segment-elevation myocardial infarction and association with coronary artery disease risk factors. Mol Diagn Ther 2011; 15: 167-176.
27. Xu MQ, Ye Z, Hu FB, et al. Quantitative Assessment of the Effect of Angiotensinogen Gene Polymorphisms on the Risk of Coronary Heart Disease. Circulation 2007; 116: 1356-1366. (Pubitemid 47417561)
28. Lotta LA and Peyvandi F. Addressing the complexity of cardiovascular disease by design. Lancet 2011; 377: 356-358.
29. Reilly MP, Li M, He J, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011; 377: 383-392.
30. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-180.
31. Horiuchi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 1999; 33: 613-621. (Pubitemid 29091636)
32. Henrion D, Kubis N, Levy BI. Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation. Hypertension 2001; 38: 1150-1157. (Pubitemid 34252821)
33. Sethi AA, Tybjaerg-Hansen A, Grønholdt ML, et al. Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study. Ann Intern Med 2001; 134: 941-954. (Pubitemid 32466233)
34. Liu Y, Jin W, Jiang ZW, et al. Correlation between TI74M and M235T Polymorphism of Angiotensinogen Gene and Coronary Heart Disease. J Diagn Concepts Pract 2002; 1: 231-236.